» Articles » PMID: 34887659

Extracellular Vesicles from HIF-1α-Overexpressing Adipose-Derived Stem Cells Restore Diabetic Wounds Through Accelerated Fibroblast Proliferation and Migration

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2021 Dec 10
PMID 34887659
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Inhibition of cellular adaptation to hypoxia can cause persistent inflammation, thereby increasing tissue damage and complicating wound healing in diabetes patients. Regulating cellular adaptation to hypoxic environments can help in effective wound repair. Hypoxia-inducible factor (HIF)-1 is a key regulator of cell hypoxia. Extracellular vesicles (EVs) regulate wound repair. This study investigated the mechanism of HIF-1α overexpression in adipose-derived stem cell extracellular vesicles (ADSCs-hEVs) in the repair of diabetic wounds.

Materials And Methods: HIF-1α expression in diabetes patients and healthy participants was studied. High-throughput sequencing, GO, and KEGG analysis revealed that ADSCs small extracellular vesicle hypoxia environments may increase HIF-1α expression by affecting cell metabolism, differentiation, and TGF-β secretion, or by altering the PI3K/AKT pathway. Effect of addition of ADSCs-hEVs on cell proliferation and migration was investigated using Western blotting, EdU assay, transwell assay, and migration. In vivo, after 7, 14, and 21 days, important factors for diabetic wound healing were evaluated by immunohistochemistry, qRT-PCR, Masson staining, and H&E staining.

Results: HIF-1α expression decreased in the skin of diabetes patients; interleukin (IL)-6 expression increased, and growth factor-related indexes decreased. ADSCs-hEVs significantly increased the expression and secretion of growth factors, compared with ADSCs-EVs. In vivo, ADSC-hEV treatment accelerated the healing rate and improved the healing quality of diabetic wounds compared with ADSCs-EVs.

Conclusion: Speed and quality of wound healing increased significantly in the ADSCs-hEVs group, which could inhibit early inflammation while promoting the secretion and expression of growth factors and extracellular matrix-related indexes.

Citing Articles

Could hypoxic conditioning augment the potential of mesenchymal stromal cell-derived extracellular vesicles as a treatment for type 1 diabetes?.

Forkan C, Shrestha A, Yu A, Chuang C, Pociot F, Yarani R Stem Cell Res Ther. 2025; 16(1):37.

PMID: 39901225 PMC: 11792614. DOI: 10.1186/s13287-025-04153-4.


Therapeutic potential of adipose-derived stem cell extracellular vesicles: from inflammation regulation to tissue repair.

Zhou B, Chen Q, Zhang Q, Tian W, Chen T, Liu Z Stem Cell Res Ther. 2024; 15(1):249.

PMID: 39113098 PMC: 11304935. DOI: 10.1186/s13287-024-03863-5.


Efficacy of MSC-derived small extracellular vesicles in treating type II diabetic cutaneous wounds: a systematic review and meta-analysis of animal models.

Yue G, Li Y, Liu Z, Yu S, Cao Y, Wang X Front Endocrinol (Lausanne). 2024; 15():1375632.

PMID: 39076515 PMC: 11284036. DOI: 10.3389/fendo.2024.1375632.


Preclinical Therapeutic Efficacy of Extracellular Vesicles Derived from Adipose-Derived Mesenchymal Stromal/Stem Cells in Diabetic Wounds: a Systematic Review and Meta-Analysis.

Soltani S, Zahedi A, Vergara A, Noli M, Soltysik F, Pociot F Stem Cell Rev Rep. 2024; 20(8):2016-2031.

PMID: 38970763 DOI: 10.1007/s12015-024-10753-z.


Recent advances in the use of extracellular vesicles from adipose-derived stem cells for regenerative medical therapeutics.

Yang S, Sun Y, Yan C J Nanobiotechnology. 2024; 22(1):316.

PMID: 38844939 PMC: 11157933. DOI: 10.1186/s12951-024-02603-4.


References
1.
Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

2.
Houreld N . Shedding light on a new treatment for diabetic wound healing: a review on phototherapy. ScientificWorldJournal. 2014; 2014:398412. PMC: 3913345. DOI: 10.1155/2014/398412. View

3.
Francia P, Anichini R, Seghieri G, De Bellis A, Gulisano M . History, Prevalence and Assessment of Limited Joint Mobility, from Stiff Hand Syndrome to Diabetic Foot Ulcer Prevention: A Narrative Review of the Literature. Curr Diabetes Rev. 2017; 14(5):411-426. PMC: 6343166. DOI: 10.2174/1573399813666170816142731. View

4.
Ahluwalia A, Tarnawski A . Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem. 2012; 19(1):90-7. DOI: 10.2174/092986712803413944. View

5.
Tekin D, Dursun A, Xi L . Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacol Sin. 2010; 31(9):1085-94. PMC: 4002308. DOI: 10.1038/aps.2010.132. View